SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-07-059017
Filing Date
2007-03-20
Accepted
2007-03-20 12:29:25
Documents
4
Period of Report
2007-03-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 15013
2 SUBSCRIPTION AGREEMENT dex1011.htm EX-10.11 289555
3 PRESS RELEASE dex991.htm EX-99.1 7109
4 GRAPHIC g66881img001.jpg GRAPHIC 13575
  Complete submission text file 0001193125-07-059017.txt   332190
Mailing Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277
Business Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51462 | Film No.: 07705582
SIC: 2836 Biological Products, (No Diagnostic Substances)